Cover Image
close this bookManagement of Uncomplicated Malaria and the Use of Antimalarial Drugs for Protection of Travellers (WHO - OMS, 1995, 108 p.)
View the document(introduction...)
View the document1. INTRODUCTION
Open this folder and view contents2. MALARIA DIAGNOSIS
Open this folder and view contents3. PRINCIPLES OF CLINICAL MANAGEMENT
Open this folder and view contents4. ACCESSORY TREATMENT
Open this folder and view contents5. PRINCIPLES OF USE OF DRUGS FOR PROTECTION
Open this folder and view contents6. ANTIMALARIAL DRUGS
Open this folder and view contents7. REGULATORY POLICIES
View the documentREFERENCES
View the documentANNEX 1. LIST OF PARTICIPANTS
View the documentANNEX 2. DRUG SCHEDULES OF ANTIMALARIAL DRUGS FOR TREATMENT AND PROPHYLAXIS
View the documentANNEX 3. ANTIMALARIAL DRUGS: SALT-BASE EQUIVALENTS

(introduction...)

Report of an Informal Consultation
Geneva, 18-21 September 1995

World health Organization
Division of Control of tropical Diseases

WORLD HEALTH ORGANIZATION

DISTR.: LIMITED
WHO/MAL/96.1075 Rev.1 (1997)
ORIGINAL: ENGLISH

This document is not issued to the general public, and all right are reserved by the World Health Organization (WHO). The document may not be reviewed, abstracted, quoted, reproduced or translated, in part or in whole, without the prior written permission of WHO. No part of this document may be stored in a retrieval system or transmitted in any form or by any means - electronic, mechanical or other - without prior written permission of WHO.

The views expressed in documents by named authors are solely the responsibility of those authors.

Ce document n’est pas destine à être distribué au grand public et tous les droits y afférents sont réservés par l’Organisation Mondiale de la Santé (OMS). II ne peut être commenté, résumé, cité, reproduit ou traduit, partiellement ou en totalité, sans une autorisation préalable écrite de l’OMS. Aucune partie ne doit être chargée dans un système de recherche documentaire ou diffusée sous quelque forme ou par quelque moyen que ce soit - électronique, mécanique, ou autre - sans une autorisation préalable écrite de l’OMS

Les opinions exprimées dans les documents par des auteurs cites nommément n’engagent que lesdits auteurs.

PLEASE NOTE

This revision contains minor editorial corrections from the original document WHO/MAL/96.1075 as well as additional material on mefloquine formulations (see footnote to p33), on adverse reactions to mefloquine (see footnote to p 36) and modifications to the recommended prophylactic regimens for mefloquine use in children (see Annex 2, section 3.3 p 94).